GITR ligand-mediated local expansion of regulatory T cells and immune privilege of corneal allografts

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 12, 2010, Pages 6556-6565

  Hori, Junko ^a   Taniguchi, Hiroko ^a   Wang, Mingcong ^a   Oshima, Masamichi ^b   Azuma, Miyuki ^c  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR LIGAND; IMMUNOGLOBULIN G; INTERLEUKIN 2 RECEPTOR ALPHA; MEMBRANE PROTEIN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR CHAMBER ASSOCIATED IMMUNE DEVIATION; ANTERIOR EYE CHAMBER; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DESTRUCTION; CELL EXPANSION; CELL PROTECTION; CILIARY BODY; CONTROLLED STUDY; CORNEA ALLOGRAFT; CORNEA ENDOTHELIUM; CORNEA TRANSPLANTATION; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; ENDOTHELIUM CELL; FOXP3+ CD4+ CD25+ REGULATORY T LYMPHOCYTE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; IRIS; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; T CELL DEPLETION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTERIOR CHAMBER; CORNEA; CORNEAL TRANSPLANTATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FORKHEAD TRANSCRIPTION FACTORS; GLUCOCORTICOID-INDUCED TNFR-RELATED PROTEIN; GRAFT SURVIVAL; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LIGANDS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPLEEN; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTORS;

EID: 77956832325     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4959     Document Type: Article

References (60)

1. Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature [Review]. Nat Rev Immunol. 2003;3:879-889.
2. Niederkorn JY. See no evil, hear no evil, do no evil: the lessons of immune privilege [Review]. Nat Rev Immunol. 2006;7:354-359.
3. Coster DJ, Williams KA. The impact of corneal allograft rejection of the long-term outcome of corneal transplantation. Am J Ophthalmol. 2005;140:1112-1122.
4. Al-Yousuf N, Mavrikakis I, Mavrikakis M, Daya SM. Penetrating keratoplasty: indications over a 10 year-period. Br J Ophthalmol. 2004;88:998-1001.
5. Randleman JB, Stulting RD. Prevention and treatment of corneal graft rejection: current practice patterns (2004). Cornea. 2006;25:286-290.
6. Hori J. Mechanisms of immune privilege in the anterior segment of the eye: what we learn from corneal transplantation. J Ocul Biol Dis Inform. 2008;1:94-100.
7. Sonoda Y, Streilein JW. Orthotopic corneal transplantation in mice-evidence that the immunogeneic rules of rejection do not apply. Transplantation. 1992;54:694-704.
8. Williams KA, Coster DJ. Penetrating corneal transplantation in the inbred rat: a new model. Invest Ophthalmol Vis Sci. 1985;26:23-30.
9. Sonoda Y, Streilein JW. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allograft. J Immunol. 1993;150:1727-1734.
10. Streilein JW, Toews GB, Bergstresser PR. Corneal allografts fail to express Ia antigens. Nature. 1979;282:326-327.
11. Sosnova M, Bradl M, Forrester JV. CD34+ corneal stromal cells are bone marrow-derived and express hemopoietic stem cells markers. Stem Cells. 2005;23:507-515.
12. Hamrah P, Zhang Q, Liu Y, Dana MR. Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells. Invest Ophthalmol Vis Sci. 2002;43:639-646.
13. Whitsett CF, Stulting RD. The distribution of HLA antigens on human corneal tissue. Invest Ophthalmol Vis Sci. 1984;25:519-524.
14. Wang HM, Kaplan HJ, Chan WC, Johnson M. The distribution and ontogeny of MHC antigens in murine ocular tissue. Invest Ophthalmol Vis Sci. 1987;28:1383-1389.
15. Treseler PA, Sanfilippo F. The expression of major histocompatibility complex and leukocyte antigens by cells in the rat cornea. Transplantation. 1986;41:248-252.
16. Kaplan HJ, Streilein JW. Immune response to immunization via the anterior chamber of the eye, I: F1 lymphocyte-induced immune deviation. J Immunol. 1977;118:809-814.
17. Niederkorn JY. Anterior chamber-associated immune deviation and its impact on corneal allograft survival. Curr Opin Organ Transplant. 2006;11:360-365.
18. Sonoda Y, Ksander B, Streilein JW. Evidence that active suppression contributes to the success of H-2-incompatible orthotopic corneal allografts in mice. Transplant Proc. 1993;25(1 pt 2):1374-1376.
19. Namba K, Kitaichi N, Nishida T, Taylor AW. Identification a-melanocyte stimulating hormone and transforming growth factor-β2. J Leukoc Biol. 2002;72:946-952.
20. Kaiser CJ, Ksander BR, Streilein JW. Inhibition of lymphocyte proliferation by aqueous humor. Reg Immunol. 1989;2:42-49.
21. Taylor AW, Yee DG, Streilein JW. Suppression of nitric oxide generated by inflammatory macrophages by calcitonin gene-related peptide in aqueous humor. Invest Ophthalmol Vis Sci. 1998;39:1372-1378.
22. Willbanks GA, Mammolenti MM, Streilein JW. Studies on the induction of anterior chamber-associated immune deviation (ACAID), III: induction of ACAID depends upon intraocular transforming growth factor-b. Eur J Immunol. 1992;22:165-173.
23. Sheibani N, Sorenson CM, Cornelius LA, Frazier WA. Thrombospondin-1, a natural inhibitor of angiogenesis, is present in vitreous and aqueous humor and is modulated by hyperglycemia. Biochem Biophys Res Commun. 2000;267:257-268.
24. Apte RS, Sinha D, Mayhew E, Wistow GL, Niederkorn JY. Role of macrophage migration inhibitory factor in inhibition NK cell activity. J Immunol. 1998;160:5693-5696.
25. Kennedy MC, Rosenbaum JT, Brown J. Novel production of interleukin-1 receptor antagonist peptides in normal human cornea. J Clin Invest. 1995;95:82-88.
26. Shon JH, Kaplan HJ, Suk HJ, Bora PS, Bora NS. Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59. Invest Ophthalmol Vis Sci. 2000;41:4195-4202.
27. Sugita S, Taguchi C, Takase H, et al. Soluble Fas ligand and soluble Fas in ocular fluid of patients with uveitis. Br J Ophthalmol. 2000;84:1130-1134.
28. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. FAS ligand-induced apoptosis as a mechanism of immune privilege. Science. 1995;270:1189-1192.
29. Hori J, Wang MC, Miyashita M, et al. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J Immunol. 2006;177:5928-5935.
30. Stuart PM, Griffith TS, Usui N, Pepose J, Yu X, Ferguson X. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest. 1997;99:396-402.
31. Hori J, Joyce N, Streilein JW. Epithelium-deficient corneal allografts display immune privilege beneath the kidney capsule. Invest Ophthalmol Vis Sci. 2000;41:443-452.
32. Hori J, Joyce NC, Streilein JW. Immune privilege and immunogenicity reside among layers of the mouse cornea. Invest Ophthalmol Vis Sci. 2000;41:3032-3042.
33. Nocentini G, Giunchi L, Ronchetti S, et al. A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc Natl Acad Sci U S A. 1997;94:6216-6221.
34. Gurney AL, Marsters SA, Huang RM, et al. Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR. Curr Biol. 1999;9:215-218.
35. Kanamaru F, Youngnak P, Hashiguchi M, et al. Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells. J Immunol. 2004;172:7306-7314.
36. Yu KY, Kim HS, Song SY, Min SS, Jeong JJ, Youn BS. Identification of a ligand for glucocorticoid-induced tumor necrosis factor receptor constitutively expressed in dendritic cells. Biochem Biophys Res Commun. 2003;310:433-438.
37. Tone M, Tone Y, Adams E, et al. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc Natl Acad Sci U S A. 2003;100:15059-15064.
38. Cuzzocrea S, Nocentini G, Di Paola R, et al. Glucocorticoid-induced TNF receptor family gene (GITR) knockout mice exhibit a resistance to splanchnic artery occlusion (SAO) shock. J Leukocyte Biol. 2004;76:933-940.
39. Agostini M, Cenci E, Pericolini E, et al. The glucocorticoid-induced tumor necrosis factor receptor-related gene modulates the response to Candida albicans infection. Infect Immun. 2005;73:7502-7508.
40. Cuzzocrea S, Ayroldi E, Di Paola R, et al. Role of glucocorticoidinduced TNF receptor family gene (GITR) in collagen-induced arthritis. FASEB J. 2005;19:1253-1265.
41. Cuzzocrea S, Nocentini G, Di Paola R, et al. Proinflammatory role of glucocorticoid-induced TNF receptor-related gene in acute lung inflammation. J Immunol. 2006;177:631-641.
42. Santucci L, Agostini M, Bruscoli S, et al. GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice. Gut. 2007;56:52-60.
43. Cuzzocrea S, Ronchetti S, Genovese T, et al. Genetic and pharmacological inhibition of GITR-GITRL interaction reduces chronic lung injury induced by bleomycin instillation. FASEB J. 2007;21:117-129.
44. Ronchetti S, Zollo O, Bruscoli S, et al. GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur J Immunol. 2004;34:613-622.
45. Esparza EM, Arch RH. Glucocorticoid-induced TNF receptor, a costimulatory receptor on naive and activated T cells, uses TNF receptor-associated factor 2 in a novel fashion as an inhibitor of NF-B activation. J Immunol. 2005;174:7875-7882.
46. Stephens GL, McHugh RS, Whitters MJ, et al. Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J Immunol. 2004;173:5008-5020.
47. Ji HB, Liao G, Faubion WA, et al. Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression. J Immunol. 2004;172:5823-5827.
48. Kim BJ, Li Z, Fariss RN, et al. Constitutive and cytokine-induced GITR ligand expression on human retinal pigment epithelium and photoreceptors. Invest Ophthalmol Vis Sci. 2004;45:3170-3176.
49. Mahesh SP, Li Z, Liu B, Fariss RN, Nussenblatt RB. Expression of GITR ligand abrogates immunosuppressive function of ocular tissue and differentially modulates inflammatory cytokines and chemokines. Eur J Immunol. 2006;36:2128-2138.
50. Chauhans SK, Saban DR, Lee HK, Dana R. Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. J Immunol. 2009;182:148-153.
51. Igarashi H, Cao Y, Iwai H, et al. GITR ligand-costimulation activates effector and regulatory functions of CD4+ T cells. Biochem Biophys Res Commun. 2008;369:1134-1138.
52. Kamimura Y, Iwai H, Piao J, Hashiguchi M, Azuma M. The glucocorticoid-induced TNF receptor-related protein (GITR) ligand pathway acts as a mediator of cutaneous dendritic cell migration and promotes T cell-mediated acquired immunity. J Immunol. 2009;182:2708-2716.
53. Hori J, Streilein JW. Dynamics of donor cell persistence and recipient cell replacement in orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci. 2001;42:1820-1828.
54. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol. 2002;3:135-142.
55. Ko K, Yamazaki S, Nakamura K, et al. Treatment of advanced tumors with agonistic anti-GITR mAn and its effects on tumor-infiltrating Foxp3+CD25+CD4+regulatory T cells. J Ext Med. 2005;202:885-891.
56. La S, Kim E, Kwon B. In vivo ligation of glucocorticoid-induced TNF receptor enhances the T-cell immunity to herpes simplex virus type 1. Exp Mol Med. 2005;37:193-198.
57. Zhou P, Litalien L, Hodges D, Schebye XM. Pivotal roles of CD4+ effector T cells in mediating agonistic anti-GITR mAb-inducedimmune activation and tumor immunity in CT26 tumors. J Immunol. 2007;179:7365-7375.
58. Hori J. Molecular mechanisms of immune-suppressive microenvironment in the cornea. Cornea. 2009;28:s58-s64.
59. Niederkorn JY, Chiang EY, Ungchusri T, Stroynowski I. Expression of a nonclassical MHC class 1b molecule in the eye. Transplantation. 1999;68:1790-1799.
60. Bora NS, Gobleman CI, Atkinson JP, Pepose JS, Kaplan HJ. Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol Vis Sci. 1993;34:3579-3584.